vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and PennyMac Mortgage Investment Trust (PMT). Click either name above to swap in a different company.
PennyMac Mortgage Investment Trust is the larger business by last-quarter revenue ($93.6M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -13.3%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 12.3%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
PennyMac Mortgage Investment Trust is a U.S.-headquartered real estate investment trust specializing in residential mortgage assets. It invests in performing and non-performing mortgage loans, mortgage-backed securities, and credit risk transfer instruments, operating across investment management and mortgage servicing segments in the U.S. housing market.
PBYI vs PMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $93.6M |
| Net Profit | — | $52.4M |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | 38.6% |
| Net Margin | — | 56.0% |
| Revenue YoY | 27.7% | -13.3% |
| Net Profit YoY | — | 12.5% |
| EPS (diluted) | $0.26 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $93.6M | ||
| Q3 25 | $54.5M | $99.2M | ||
| Q2 25 | $52.4M | $70.2M | ||
| Q1 25 | $46.0M | $44.5M | ||
| Q4 24 | $59.1M | $107.9M | ||
| Q3 24 | $80.5M | $80.9M | ||
| Q2 24 | $47.1M | $71.2M | ||
| Q1 24 | $43.8M | $74.2M |
| Q4 25 | — | $52.4M | ||
| Q3 25 | $8.8M | $58.3M | ||
| Q2 25 | $5.9M | $7.5M | ||
| Q1 25 | $3.0M | $9.7M | ||
| Q4 24 | — | $46.5M | ||
| Q3 24 | $20.3M | $41.4M | ||
| Q2 24 | $-4.5M | $25.4M | ||
| Q1 24 | $-4.8M | $47.6M |
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
| Q4 25 | 22.7% | 38.6% | ||
| Q3 25 | 17.6% | 47.4% | ||
| Q2 25 | 12.7% | 24.2% | ||
| Q1 25 | 8.7% | -14.2% | ||
| Q4 24 | 22.6% | 51.1% | ||
| Q3 24 | 27.4% | 32.8% | ||
| Q2 24 | -4.6% | 40.2% | ||
| Q1 24 | -5.3% | 43.6% |
| Q4 25 | — | 56.0% | ||
| Q3 25 | 16.2% | 58.7% | ||
| Q2 25 | 11.2% | 10.7% | ||
| Q1 25 | 6.5% | 21.8% | ||
| Q4 24 | — | 43.1% | ||
| Q3 24 | 25.2% | 51.2% | ||
| Q2 24 | -9.6% | 35.7% | ||
| Q1 24 | -11.0% | 64.2% |
| Q4 25 | $0.26 | $0.49 | ||
| Q3 25 | $0.17 | $0.55 | ||
| Q2 25 | $0.12 | $-0.04 | ||
| Q1 25 | $0.06 | $-0.01 | ||
| Q4 24 | $0.40 | $0.45 | ||
| Q3 24 | $0.41 | $0.36 | ||
| Q2 24 | $-0.09 | $0.17 | ||
| Q1 24 | $-0.10 | $0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $190.5M |
| Total DebtLower is stronger | $22.7M | $1.1B |
| Stockholders' EquityBook value | $130.3M | $1.9B |
| Total Assets | $216.3M | $21.3B |
| Debt / EquityLower = less leverage | 0.17× | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $190.5M | ||
| Q3 25 | $94.4M | $181.0M | ||
| Q2 25 | $96.0M | $108.6M | ||
| Q1 25 | $93.2M | $204.2M | ||
| Q4 24 | $101.0M | $103.2M | ||
| Q3 24 | $96.7M | $102.8M | ||
| Q2 24 | $96.8M | $336.3M | ||
| Q1 24 | $107.2M | $343.3M |
| Q4 25 | $22.7M | $1.1B | ||
| Q3 25 | $34.0M | $299.0M | ||
| Q2 25 | $45.3M | $1.2B | ||
| Q1 25 | $56.7M | $968.4M | ||
| Q4 24 | $68.0M | $1.0B | ||
| Q3 24 | $79.3M | $5.2B | ||
| Q2 24 | $90.7M | $5.4B | ||
| Q1 24 | $102.0M | $5.1B |
| Q4 25 | $130.3M | $1.9B | ||
| Q3 25 | $115.3M | $1.9B | ||
| Q2 25 | $104.7M | $1.9B | ||
| Q1 25 | $97.1M | $1.9B | ||
| Q4 24 | $92.1M | $1.9B | ||
| Q3 24 | $71.1M | $1.9B | ||
| Q2 24 | $48.5M | $1.9B | ||
| Q1 24 | $51.0M | $2.0B |
| Q4 25 | $216.3M | $21.3B | ||
| Q3 25 | $202.9M | $18.5B | ||
| Q2 25 | $194.9M | $16.8B | ||
| Q1 25 | $196.2M | $14.9B | ||
| Q4 24 | $213.3M | $14.4B | ||
| Q3 24 | $220.7M | $13.1B | ||
| Q2 24 | $205.0M | $12.1B | ||
| Q1 24 | $214.1M | $12.3B |
| Q4 25 | 0.17× | 0.58× | ||
| Q3 25 | 0.30× | 0.16× | ||
| Q2 25 | 0.43× | 0.65× | ||
| Q1 25 | 0.58× | 0.51× | ||
| Q4 24 | 0.74× | 0.52× | ||
| Q3 24 | 1.12× | 2.70× | ||
| Q2 24 | 1.87× | 2.76× | ||
| Q1 24 | 2.00× | 2.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $-7.2B |
| Free Cash FlowOCF − Capex | $14.4M | — |
| FCF MarginFCF / Revenue | 19.1% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | -137.76× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $-7.2B | ||
| Q3 25 | $9.7M | $-1.3B | ||
| Q2 25 | $14.1M | $-2.0B | ||
| Q1 25 | $3.6M | $-594.3M | ||
| Q4 24 | $15.6M | $-2.7B | ||
| Q3 24 | $11.0M | $-983.8M | ||
| Q2 24 | $1.0M | $243.8M | ||
| Q1 24 | $11.2M | $-342.4M |
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | -137.76× | ||
| Q3 25 | 1.10× | -22.26× | ||
| Q2 25 | 2.41× | -267.53× | ||
| Q1 25 | 1.21× | -61.39× | ||
| Q4 24 | — | -58.08× | ||
| Q3 24 | 0.54× | -23.76× | ||
| Q2 24 | — | 9.59× | ||
| Q1 24 | — | -7.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
PMT
| Other | $55.0M | 59% |
| Interest Rate Sensitive Strategies | $31.4M | 34% |
| Correspondent Production | $7.2M | 8% |
